LeMaitre Vascular Community

NasdaqGM:LMAT Community

1 Narratives written by author
0 Comments on narratives written by author
6 Fair Values set on narratives written by author

LeMaitre Vascular

AN

AnalystConsensusTarget

Consensus Narrative from 8 Analysts

Launching XenoSure In China And Obtaining MDR CE Marks Will Strengthen Future Prospects

Key Takeaways Expanding the sales force and launching products in new international markets, like China, drives revenue growth and top-line expansion. Enhancing operational efficiency through digital manufacturing and strategic pricing actions improves margins and future earnings.

US$105.63

FV

15.2% undervalued

8.79%

Revenue growth p.a.

0

0

2

Updated